Flesh-colored to red-brown nonpruritic papules developed most prominently on the elbows, forearms, and knees of a 2 1⁄2-year-old boy. The rash was preceded by a low-grade fever and mild, upper respiratory tract symptoms.
Flesh-colored to red-brown nonpruritic papules developed most prominently on the elbows, forearms, and knees of a 2 1⁄2-year-old boy. The rash was preceded by a low-grade fever and mild, upper respiratory tract symptoms.
On physical examination, no hepatosplenomegaly was detected. A clinical diagnosis of Gianotti-Crosti syndrome, or papular acrodermatitis, was made by Drs Charles E. Crutchfield III and Humberto Gallego of Eagan, Minn.
Gianotti-Crosti syndrome is self-limited. It is seen in children, particularly youngsters between 2 and 5 years of age who have viral infections, including those caused by Epstein-Barr virus, coxsackievirus, and hepatitis B virus. If hepatic symptoms are present at the initial diagnosis, reexamine the child in 4 to 6 weeks; patients without liver involvement need routine follow-up to monitor for the development of hepatic disorders.
Mild postinflammatory hyperpigmentation may follow rash resolution; generally, it will fade in a few months. Corticosteroids usually are of no benefit in treating this condition. Reassure the patient (and parents) that the disease is self-limited and will resolve in approximately 2 months. This young boy's symptoms cleared 7 weeks after they first appeared.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.